Actively Recruiting
Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
Led by Foundation University Islamabad · Updated on 2026-04-14
46
Participants Needed
1
Research Sites
10 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
CONDITIONS
Official Title
Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 45 years
- Both male and female genders eligible
- Dyspnea grade 1 to 3 on mMRC scale
- Diagnosed with mild persistent, intermediate, or moderate persistent asthma according to NAEPP 2020 guidelines
You will not qualify if you...
- Acute exacerbation of COPD or status asthmaticus
- Acute infection diagnosis
- Unable to follow commands or instructions
- Asthma patients with control pause duration greater than 40 seconds
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Foundation University Islamabad
Islamabad, Pakistan
Actively Recruiting
Research Team
M
Maryam Arooj, MSPT-CPPT
CONTACT
Z
Zara Khalid, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here